Cargando…

Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Several genome-wide association studies (GWAS) have been conducted to identify the common single nucleotide polymorphisms (SNPs) that influence the risk of prostate cancer. It was hypothesized that some prostate cancer-associated SNPs might relate to the clinical outcomes in patients treated for pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shu-Pin, Bao, Bo-Ying, Hour, Tzyh-Chyuan, Huang, Chao-Yuan, Yu, Chia-Cheng, Liu, Chia-Chu, Lee, Yung-Chin, Huang, Chun-Nung, Pao, Jiunn-Bey, Huang, Chun-Hsiung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402522/ https://www.ncbi.nlm.nih.gov/pubmed/22844442 http://dx.doi.org/10.1371/journal.pone.0041219

Ejemplares similares

Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer
por: Yu, Chia-Cheng, et al.
Publicado: (2013)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
por: Huang, Ling-Chun, et al.
Publicado: (2022)

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy
por: Geng, Jiun-Hung, et al.
Publicado: (2016)

Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
por: Liao, Kuang-Ming, et al.
Publicado: (2019)

Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer’s Disease Patients and Patients’ Adult Children
por: Huo, Chieh, et al.
Publicado: (2022)

NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
por: Huang, Shu-Pin, et al.
Publicado: (2021)

Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference
por: Fu, Yu-Ke, et al.
Publicado: (2022)

Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2020)

Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder
por: Chung, Shiu-Dong, et al.
Publicado: (2017)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
por: Lai, Chih-Jen, et al.
Publicado: (2019)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
por: Hou, Wei-Hsien, et al.
Publicado: (2017)

Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
por: Yunfeng, Gao, et al.
Publicado: (2017)

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
por: Johnson, Matthew E., et al.
Publicado: (2012)

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy
por: Lee, Cheng-Hsueh, et al.
Publicado: (2016)

Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020)

Predictive Clinical Indicators of Biochemical Progression in Advanced Prostate Cancer Patients Receiving Leuplin Depot as Androgen Deprivation Therapy
por: Chen, Chien-Hua, et al.
Publicado: (2014)

No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study
por: Kao, Li-Ting, et al.
Publicado: (2017)

The Promotion of Migration and Myogenic Differentiation in Skeletal Muscle Cells by Quercetin and Underlying Mechanisms
por: Hour, Tzyh-Chyuan, et al.
Publicado: (2022)

Salvage Radiotherapy Plus Androgen Deprivation Therapy for High-Risk Prostate Cancer with Biochemical Failure after High-Intensity Focused Ultrasound as Primary Treatment
por: Huang, Ying-Che, et al.
Publicado: (2022)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

IL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis
por: Suen, Jau‐Ling, et al.
Publicado: (2019)

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
por: Liu, Jui-Ming, et al.
Publicado: (2021)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis
por: Liu, Wantao, et al.
Publicado: (2023)

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma
por: Pu, Yeong-Shiau, et al.
Publicado: (2009)

Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study
por: Lin, Hsin-Le, et al.
Publicado: (2022)

Unsupervised Integration of Multiple Protein Disorder Predictors: The Method and Evaluation on CASP7, CASP8 and CASP9 Data
por: Zhang, Ping, et al.
Publicado: (2011)

Androgen Deprivation Therapy and Cardiovascular Risk in Chinese Patients with Nonmetastatic Carcinoma of Prostate
por: Huang, Gang, et al.
Publicado: (2014)

Clinical predictor of survival following docetaxel-based chemotherapy
por: LEE, HSIANG-YING, et al.
Publicado: (2014)

Androgen deprivation modulates the inflammatory response induced by irradiation
por: Wu, Chun-Te, et al.
Publicado: (2009)

A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
por: Shore, Richard, et al.
Publicado: (2021)

Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival
por: Bao, Bo-Ying, et al.
Publicado: (2016)

The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males
por: Cheng, Kai-Hung, et al.
Publicado: (2013)

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma
por: Lee, Chi-Ho, et al.
Publicado: (2017)

CASP+ Practice Tests
por: Tanner, Nadean
Publicado: (2020)

Purified Astaxanthin from Haematococcus pluvialis Promotes Tissue Regeneration by Reducing Oxidative Stress and the Secretion of Collagen In Vitro and In Vivo
por: Chou, Hsin-Yu, et al.
Publicado: (2020)

The use of androgen deprivation therapy for prostate cancer and its effect on the subsequent dry eye disease: a population-based cohort study
por: Chien, Hsiang-Wen, et al.
Publicado: (2022)

Lower SHBG level is associated with higher leptin and lower adiponectin levels as well as metabolic syndrome, independent of testosterone
por: Liu, Chia-Chu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8kvr6kritalhsd1visv2eo2pk1